Detection of risk groups in myelodysplastic syndromes. A multicenter study

Haematologica

Volumn 87, Issue 1, 2002, Pages 9-16

  Belli, Carolina ^a   Acevedo, Susana ^a   Bengio, Raquel ^a   Arrossagaray, Guillermo ^a   Watman, Nora ^a   Rossi, Norma ^a   García, Juan ^a   Flores, Gabriela ^a   Goldztein, Sofía ^a   Larripa, Irene ^a  

^a NONE   (Argentina)

Author keywords

IPSS; Leukemic evolution; Myelodysplastic syndromes; Prognostic variables

Indexed keywords

ARGENTINA; ARTICLE; CANCER CLASSIFICATION; CANCER RISK; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; CYTOGENETICS; CYTOPENIA; DISEASE COURSE; FOLLOW UP; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; INTERNATIONAL PROGNOSTIC SCORING SYSTEM; LEUKEMIA; MAJOR CLINICAL STUDY; MYELOBLAST; MYELODYSPLASTIC SYNDROME; PATIENT CODING; PRODUCTIVITY; RISK ASSESSMENT; SCORING SYSTEM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; ARGENTINA; BLOOD CELL COUNT; BONE MARROW; BONE MARROW EXAMINATION; CELL LINEAGE; CHROMOSOME ABERRATIONS; DISEASE PROGRESSION; FEMALE; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID; LIFE TABLES; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; PRELEUKEMIA; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 0036154472     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: A report on 408 cases
2. Myelodysplastic syndromes (MDS). Aspect of hematopathologic diagnosis
3. Chromosomal alterations associated with evolution from myelodysplastic syndrome to acute myeloid leukemia
4. Proposals for the classification of the myelodysplastic syndromes
5. Bone marrow histology in myelodysplastic syndromes. II. Prognostic value of abnormal localization of immature precursors in MDS
6. Myelodysplastic syndromes: A scoring system with prognostic significance
7. Primary myelodysplastic syndromes: Analysis of prognostic factors in 235 patients and proposal for an improved scoring system
8. Prediction of 18-month survival in patients with primary myelodysplastic syndrome. A regression model and scoring system based on the combination of chromosome findings and the Bournemouth score
9. International scoring system for evaluating prognosis in myelodysplastic syndromes
10. Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for prognosis
11. Epidemiological and etiological aspects of myelodysplastic syndromes
12. Long-term survivors in myelodysplastic syndromes: A report on 63 cases and comparison with short and intermediate survivors
13. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group
14. Cross-validation of prognostic scores in myelodysplastic syndromes on 386 patients from a single institution confirms importance of cytogenetics
15. Etiopathogeny, prognosis and therapy of myelodysplastic syndromes
16. Leukemic transformation in patients with 5q- and additional abnormalities
17. Risk factors and their relationship to prognosis in myelodysplastic syndromes
18. The 5q-anomaly
19. Diagnostic significance of cytogenetics in adult primary myelodysplastic syndromes
20. The chronic myeloid leukaemias: Guidelines for distinguishing chronic granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia
21. Prognostic features of chronic myelomonocytic leukaemia: A modified Bournemouth scores gives the best prediction of survival
22. Problems in the classification of CMML: Dysplastic versus proliferative type
23. Prognostic factors in adult chronic myelomonocytic leukemia: An analysis of 107 cases